Drugs / Travoprost/timolol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01510132 | Jan 2012 | ocular hypertension, open-angle glaucoma | Alcon Research | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Travoprost/timolol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01510132 ↗ |
| Known as | Travacom | “Travoprost/timolol fixed combination (Travacom)” NCT01510132 ↗ |